Health Economic & Outcomes Research Strategy Lead (UK)

UCB S.A.

Slough

Hybride

GBP 90 000 - 130 000

Plein temps

14 jours+

Une candidature complète en une minute

Un CV et une lettre de motivation personnalisés, prêts à envoyer.

Passez les filtres ATS

Avantages offerts par ce poste

Hybrid work model
Global exposure

Résumé du poste

UCB S.A. is seeking a strategic HEOR Strategy Lead to shape global payer evidence and HTA strategies across the product lifecycle. You will join the Patient Evidence team and influence development and commercialization with evidence generation plans.

Based in Brussels, Slough, or Monheim, this hybrid role offers collaboration across markets and functions, including real world evidence, medical affairs, and clinical development.

Qualifications

  • Master's degree or PhD in Health Economics, Market Access, Outcomes Research, Public Health, Epidemiology, Pharmacy, or related field.
  • 8+ years of pharma industry experience, including consultancy where relevant.
  • Experience in global or matrix organizations with intercontinental exposure.

Responsabilités

  • Develop and refine global HEOR and payer evidence strategies aligned with asset and market access objectives.
  • Design and deliver HEOR evidence generation activities including cost-effectiveness and budget impact models, literature reviews, and QoL studies.
  • Build asset value assessments and support pricing and value strategies.
  • Communicate economic value stories for assets and indications.
  • Influence clinical development programs to meet payer HTA requirements globally.
  • Represent HTA and payer perspectives within cross-functional teams.

Connaissances

Health economics
Outcome research
Strategic thinking
Stakeholder management
Leadership
Communication skills

Formation

Master's degree or PhD in Health Economics or related field

Outils

HEOR modelling tools

Description du poste

Make your mark for patients

We are looking for a Health Economics & Outcomes Research Strategy Lead who is strategic, analytical, and influential to join our Patient Evidence team, helping shape global evidence strategies that support successful payer, HTA, and reimbursement outcomes for UCB's portfolio based in Brussels, Belgium; Slough, UK or Monheim, Germany.

About the Role

As HEOR Strategy Lead, you will be responsible for developing and executing global Health Economics & Outcomes Research (HEOR) strategies aligned with HTA and payer evidence requirements across the product lifecycle.

You will act as a key member of the global payer sub-team, representing the HTA and payer perspective within evidence generation and clinical development activities. By identifying evidence gaps, informing development strategies, and connecting access objectives to robust evidence generation plans, you will play a critical role in enabling successful reimbursement and patient access.

This role offers the opportunity to influence strategic decisions from development through commercialization, ensuring evidence generation activities address the evolving needs of healthcare decision-makers worldwide.

Who You’ll Work With

You will work closely with colleagues across Market Access, Patient Evidence, Real World Evidence, Patient Centered Outcomes Research, Biostatistics & Quantitative Sciences, Clinical Development, and Medical Affairs. You will also collaborate with affiliate teams, external experts, and research partners to ensure evidence generation strategies support successful access outcomes.

What You’ll Do
  • Develop and continuously refine global HEOR and payer evidence strategies aligned with asset and market access objectives.
  • Design and deliver key HEOR evidence generation activities, including cost-effectiveness models, budget impact models, systematic literature reviews, indirect treatment comparisons, healthcare resource utilization studies, and quality-of-life research.
  • Develop asset value assessments and support economically justified pricing and value strategies.
  • Build and communicate compelling economic value stories for assigned assets and indications.
  • Influence clinical development programs to ensure evidence generation plans address payer and HTA requirements, including evolving EU HTA needs.
  • Represent HTA and payer perspectives within cross-functional evidence generation and development teams.
  • Support the creation of global value dossiers and guide affiliate teams on reimbursement and access strategies.
  • Partner with cross-functional stakeholders to execute studies that strengthen payer decision-making, including patient preference and natural history studies.
  • Integrate affiliate and market-specific payer requirements into global evidence generation plans.
  • Contribute to scientific publications, congress presentations, external partnerships, and thought leadership activities.
Interested? For this role we’re looking for:
  • Master's degree or PhD in Health Economics, Market Access, Outcomes Research, Public Health, Epidemiology, Pharmacy, or a related field.
  • At least 8 years of experience within the pharmaceutical industry, including consultancy experience where relevant.
  • Strong expertise in health economic modelling, outcomes research, and payer evidence generation.
  • Experience supporting HTA submissions, reimbursement strategies, and access initiatives across key markets.
  • Experience working in global or matrix organizations, with above-country or intercontinental exposure highly valued.
  • Strong leadership, communication, stakeholder management, and strategic thinking skills.
About us

UCB is a global biopharmaceutical company, focusing on neurology and immunology. We are over 9.000 people in all four corners of the globe, inspired by patients and driven by science.

Why work with us?

At UCB, we don’t just complete tasks, we create value. We aren’t afraid to push forward, collaborate, and innovate to make our mark for patients. We have a caring, supportive culture where everyone feels included, respected, and has equal opportunities to do their best work. We ‘go beyond’ to create value for our patients, and always with a human focus, whether that’s on our patients, our employees, or our planet. Working for us, you will discover a place where you can grow, and have the freedom to carve your own career path to achieve your full potential.

At UCB, we’ve embraced a hybrid-first approach to work, bringing teams together in local hubs to foster collaborative curiosity. Unless expressly stated in the description or precluded by the nature of the position, roles are hybrid with 40% of your time spent in the office.

UCB is an equal opportunity employer. All employment decisions will be made without regard to any characteristic protected by applicable laws.


Should you require any adjustments to our process to assist you in demonstrating your strengths and capabilities contact us on EMEA-Reasonable_Accommodation@ucb.com. Please note should your enquiry not relate to adjustments; we will not be able to support you through this channel.

Obtenez votre examen gratuit et confidentiel de votre CV.

ou faites glisser et déposez votre fichier ici.

Similar jobs

Postes similaires à comparer

Health Economic & Outcomes Research Strategy Lead (UK)
Health Economic & Outcomes Research Strategy Lead (UK)

UCB • Slough

Hybride
GBP 90 000 - 130 000
Health Economics & Outcomes Research Senior Expert - Rare Disease (UK)
Health Economics & Outcomes Research Senior Expert - Rare Disease (UK)

UCB • Slough

Hybride
GBP 90 000 - 130 000
Access & Pricing Strategy Team Lead - Immunology (United Kingdom)
Access & Pricing Strategy Team Lead - Immunology (United Kingdom)

UCB • Slough

Hybride
GBP 120 000 - 170 000
Hybrid work model
Reasonable accommodation process
Access & Pricing Strategy Lead - Neurology (United Kingdom)
Access & Pricing Strategy Lead - Neurology (United Kingdom)

UCB • Slough

Hybride
GBP 120 000 - 150 000
Access & Pricing Strategy Team Lead - Neurology (United Kingdom)
Access & Pricing Strategy Team Lead - Neurology (United Kingdom)

UCB • Slough

Hybride
GBP 90 000 - 130 000
RWE Strategy Lead, Developed Brands (UK)
RWE Strategy Lead, Developed Brands (UK)

UCB • Slough

Hybride
GBP 90 000 - 130 000
Global Payer Asset Head
Global Payer Asset Head

Ucb • Slough

Hybride
GBP 136 000 - 182 000
Global Payer Asset Head (UK)
Global Payer Asset Head (UK)

UCB • Slough

Hybride
GBP 150 000 - 190 000
Global HEOR Strategy Lead, Payer & Value Insights
Global HEOR Strategy Lead, Payer & Value Insights

UCB S.A. • Slough

Hybride
GBP 90 000 - 130 000
Hybrid work model
Global exposure
Real-World Evidence Strategy Lead, Respiratory
Real-World Evidence Strategy Lead, Respiratory

Ucb • Slough

Hybride
GBP 110 000 - 160 000